These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36645078)

  • 21. Impact of the risk of malnutrition on bleeding, mortality, and ischemic events in patients with acute myocardial infarction.
    Lim S; Choo EH; Choi IJ; Hwang Y; Lee KY; Lee SN; Hwang BH; Kim CJ; Park MW; Lee JM; Park CS; Kim HY; Yoo KD; Jeon DS; Chung WS; Kim MC; Jeong MH; Yim HW; Ahn Y; Chang K
    Nutr Metab Cardiovasc Dis; 2023 Jan; 33(1):65-74. PubMed ID: 36411222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adequate time in therapeutic INR range using triple antithrombotic therapy is not associated with long-term cardiovascular events and major bleeding complications after drug-eluting stent implantation.
    Konishi H; Miyauchi K; Kasai T; Tsuboi S; Ogita M; Naito R; Dohi T; Tamura H; Okazaki S; Daida H
    J Cardiol; 2016 Dec; 68(6):517-522. PubMed ID: 27021470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
    Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
    JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of DAPT score for prolonged dual antiplatelet therapy in patients with acute myocardial infarction.
    Veron-Esquivel D; Batiz-Armenta F; Cazares-Diazleal AC; Oviedo-Moguel S; Jarvio-Fernandez SM; Arce-Gonzalez JM; Ivey-Miranda JB
    Hellenic J Cardiol; 2019; 60(5):296-302. PubMed ID: 29807194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial.
    Bergmark BA; Bhatt DL; Steg PG; Budaj A; Storey RF; Gurmu Y; Kuder JF; Im K; Magnani G; Oude Ophuis T; Hamm C; Špinar J; Kiss RG; Van de Werf FJ; Montalescot G; Johanson P; Braunwald E; Sabatine MS; Bonaca MP
    J Am Heart Assoc; 2021 Sep; 10(17):e020446. PubMed ID: 34423649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.
    Han Y; Guo J; Zheng Y; Zang H; Su X; Wang Y; Chen S; Jiang T; Yang P; Chen J; Jiang D; Jing Q; Liang Z; Liu H; Zhao X; Li J; Li Y; Xu B; Stone GW;
    JAMA; 2015 Apr; 313(13):1336-46. PubMed ID: 25775052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
    Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
    JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Impact of prolonging dual antiplatelet therapy on long-term prognosis of elderly patients with coronary heart disease complicated with diabetes mellitus undergoing drug-eluting stent implantation].
    Xu JJ; Zhu P; Song Y; Yuan DS; Jia SD; Zhao XY; Yao Y; Jiang L; Xu N; Li JX; Zhang Y; Song L; Gao LJ; Chen JL; Qiao SB; Yang YJ; Xu B; Gao RL; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):450-457. PubMed ID: 35589593
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).
    Nikolsky E; Mehran R; Yu J; Witzenbichler B; Brodie BR; Kornowski R; Brener S; Xu K; Dangas GD; Stone GW
    Am J Cardiol; 2013 May; 111(10):1377-86. PubMed ID: 23465098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria.
    Breen TJ; Raphael CE; Ingraham B; Lane C; Huxley S; Roger VL; Jaffe A; Lewis B; Sandoval YB; Prasad A; Rihal CS; Gulati R; Singh M
    Int J Cardiol; 2024 Feb; 396():131565. PubMed ID: 37913957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis and the Effect of De-Escalation of Antiplatelet Therapy After Nuisance Bleeding in Patients With Myocardial Infarction.
    Choo EH; Choi IJ; Lim S; Moon D; Kim CJ; Park MW; Kim MC; Hwang BH; Lee KY; Seok Choi Y; Kim HY; Yoo KD; Jeon DS; Ahn Y; Chang K;
    Circ Cardiovasc Interv; 2022 Dec; 15(12):e012157. PubMed ID: 36382599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States.
    Bae JP; Faries DE; Ernst FR; Lipkin C; Zhao Z; Moretz C; Lieu HD; Effron MB
    Curr Med Res Opin; 2014 Nov; 30(11):2207-16. PubMed ID: 25034466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple antithrombotic therapy is the independent predictor for the occurrence of major bleeding complications: analysis of percent time in therapeutic range.
    Naruse Y; Sato A; Hoshi T; Takeyasu N; Kakefuda Y; Ishibashi M; Misaki M; Abe D; Aonuma K;
    Circ Cardiovasc Interv; 2013 Aug; 6(4):444-51. PubMed ID: 23941857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 30-Day MACE between Immediate versus Staged Complete Revascularization in Acute Myocardial Infarction with Multivessel Disease, and the Effect of Coronary Lesion Complexity.
    Doğan C; Bayram Z; Çap M; Özkalaycı F; Unkun T; Erdoğan E; Uslu A; Acar RD; Guvendi B; Akbal ÖY; Karagöz A; Hakgor A; Karaduman A; Uysal S; Aykan A; Kaymaz C; Özdemir N
    Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30781429
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk Assessment of Major Adverse Cardiovascular and Cerebrovascular Events and Bleeding for Acute Myocardial Infarction With or Without Active Tuberculosis.
    Xu X; Zhu H; Cai L; Liu L; Zhang F; Zhou H; Mei B; Zhu M; Dai L; Chen T; Xu K
    Clin Ther; 2022 Oct; 44(10):1370-1379. PubMed ID: 36150925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in demographics, clinical practices and long-term outcomes of patients with ST segment-elevation myocardial infarction who underwent coronary revascularisation in the past two decades: cohort study.
    Takeji Y; Shiomi H; Morimoto T; Yoshikawa Y; Taniguchi R; Mutsumura-Nakano Y; Yamamoto K; Yamaji K; Tazaki J; Kato ET; Watanabe H; Yamamoto E; Yamashita Y; Fuki M; Suwa S; Inoko M; Takeda T; Shirotani M; Ehara N; Ishii K; Inada T; Tamura T; Onodera T; Shinoda E; Yamamoto T; Watanabe H; Yaku H; Nakatsuma K; Sakamoto H; Ando K; Soga Y; Furukawa Y; Sato Y; Nakagawa Y; Kadota K; Komiya T; Minatoya K; Kimura T;
    BMJ Open; 2021 Mar; 11(3):e043683. PubMed ID: 33789850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO Trial.
    Dillinger JG; Ducrocq G; Elbez Y; Cohen M; Bode C; Pollack C; Petrauskiene B; Henry P; Dorobantu M; French WJ; Wiviott SD; Sabatine MS; Mehta SR; Steg PG
    Circ Cardiovasc Interv; 2021 Jan; 14(1):e009759. PubMed ID: 33430604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.